Literature DB >> 11079285

Pharmaceutical care of postoperative nausea and vomiting: balanced scorecard for outcomes.

J F Graumlich1, S M Belknap, S A Bullard, G A Storm, K S Brunsman, J A Howerton.   

Abstract

Using the balanced scorecard to measure outcomes, a multidisciplinary team worked to improve antiemetic therapy and decrease postoperative nausea and vomiting. Patient satisfaction measures were nausea and pain scales (10 cm, nonnumbered, visual analog). The quality measure was number of vomiting episodes. Cost measures were length of postoperative stay and antiemetic requirement. Institutional learning was assessed by spread of prescribing changes beyond the first cohort of patients. Intervention subjects were providers of general anesthesia in two cohorts of patients (60 and 346) undergoing laparoscopic cholecystectomy. Outcome assessment revealed low nausea and vomiting scores throughout the study, and antiemetic use decreased 50%. There were no deteriorations in pain scores or length of stay. Balanced scorecard measurements suggest no adverse unintended outcomes consequent to changes in prescribing behavior. Balanced scorecard processes assisted consensus among pharmacists, nurses, and physicians that may have accelerated behavioral changes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079285     DOI: 10.1592/phco.20.17.1365.34900

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  2 in total

Review 1.  [The balanced scorecard. "Tool or toy" in hospitals].

Authors:  A Brinkmann; F Gebhard; R Isenmann; U Bothner; U Mohl; B Schwilk
Journal:  Anaesthesist       Date:  2003-10       Impact factor: 1.041

2.  [Adherence to treatment guidelines for postoperative nausea and vomiting. How well does knowledge transfer result in improved clinical care?].

Authors:  M Franck; F M Radtke; A Baumeyer; P Kranke; K D Wernecke; C D Spies
Journal:  Anaesthesist       Date:  2010-06       Impact factor: 1.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.